According to Bayer's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -7.39829. At the end of 2022 the company had a P/E ratio of 11.2.
Year | P/E ratio | Change |
---|---|---|
2022 | 11.2 | -76.85% |
2021 | 48.2 | -1090.36% |
2020 | -4.86 | -127.86% |
2019 | 17.5 | -43.11% |
2018 | 30.7 | 136.5% |
2017 | 13.0 | -24.57% |
2016 | 17.2 | -24.64% |
2015 | 22.8 | -7.4% |
2014 | 24.7 | -12.11% |
2013 | 28.1 | 12.17% |
2012 | 25.0 | 65.02% |
2011 | 15.2 | -57.91% |
2010 | 36.0 | 5.99% |
2009 | 34.0 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.